Pre-IPO Xiamen Yan Palace Bioengineering (PHIP Updates) - Some Points Worth the Attention
324 Views27 Nov 2023 08:55
As Yan palace's revenue growth further declines, effectiveness of marketing activities has already decrease. Huge selling expenses erode profit margin, so it's hard to bring investors expected returns
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- Pre-IPO Xiamen Yan Palace Bioengineering (PHIP Updates) - Some Points Worth the Attention27 Nov 2023
- Hygeia Healthcare Group (6078.HK) - A Decline in Growth Is Inevitable21 Nov 2023
- WuXi XDC (2268.HK) - How Long Will the Rally Last?20 Nov 2023
- Pre-IPO Xiamen Yan Palace Bioengineering - Concerns About Profitability and Growth Sustainability07 Sep 2023
x